JW (Cayman) Therapeutics Co Ltd
F:JNY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
JW (Cayman) Therapeutics Co Ltd
F:JNY
|
CN |
|
H
|
Hexagon Energy Materials Ltd
SWB:F93
|
AU |
|
H
|
HMCIB No.5 Special Purpose Acquisition Co
KOSDAQ:353060
|
KR |
|
Interfor Corp
TSX:IFP
|
CA |
|
Banco di Desio e della Brianza SpA
MIL:BDB
|
IT |
|
C
|
Calgro M3 Holdings Ltd
F:5C2
|
ZA |
|
C
|
Cytosorbents Corp
F:HQE1
|
US |
|
S
|
Sleep Number Corp
XBER:SL2
|
US |
|
ZIGExN Co Ltd
F:ZGE
|
JP |
|
Safe & Green Holdings Corp
F:90S1
|
US |
|
District Metals Corp
F:DFPP
|
CA |
|
L
|
LightPath Technologies Inc
F:LPZB
|
US |
Bankruptcy Probability
JW (Cayman) Therapeutics Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
JW (Cayman) Therapeutics Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
785.1m HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
462.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
JW (Cayman) Therapeutics Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, JW (Cayman) Therapeutics Co Ltd has total debt of 36.2m CNY. This includes both short-term (0 CNY) and long-term (36.2m CNY) debt.
You can find a full breakdown on its Balance Sheet.
